Status:
UNKNOWN
Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Barrett Esophagus Adenocarcinoma
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Barrett's oesophagus is a transformation of the esophageal mucous membrane there intestinal metaplasia under the effect of gastro- esophageal reflux disease (GERD). This metaplasia can evolve in low ...
Eligibility Criteria
Inclusion
- Age ≥ 18 and ≤ 75 years,
- High grade dysplasia or superficial Barrett's oesophagus adenocarcinoma diagnosis,
- Written informed consent,
- Affiliation to Social Security System.
Exclusion
- Hiatal hernia,
- Surgical histories treatment of gastro- esophageal reflux disease,
- Woman pregnant or susceptible to the being,
- Patients deprived of liberty or placed Under the authority of a tutor,
- Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol or follow-up schedule,
- Contraindications to the endoscopic procedure.
Key Trial Info
Start Date :
June 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03278327
Start Date
June 27 2017
End Date
June 1 2023
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GENRE
Marseille, France, 13273